Genomics Market Size to be Worth US$ 62,614.6 Mn by 2026

Genomics Industry 2019 Fortune Business Insights report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market forecast till 2026

Pune, India - July 19, 2019 /MarketersMedia/ —

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the global genomics market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Browse Complete Report Details @
https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Genomics is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, the global market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026.

In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026. The gradual shift from traditional medicine to precision medicine is positively changing the healthcare environment. Genomics plays a crucial role in the treatment and diagnosis of chronic diseases.

Some of the Main Key Players Covered in the Report

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd
• Agilent Technologies, Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen
• General Electric Company

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region.

In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.

Get Sample PDF Brochure@
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

A Myriad of R&D Activities Has Spurred Growth Prospects for Genomics Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added.

Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.The lower costs of genetic procedures is likely to contribute to the development of the genomic market in the forthcoming years. Technological advancements in genomic medicine which include Next-generation Sequencing (NGS), Sanger sequencing, Polymerase Chain Reactions (PCR), and microarray are likely to drive the market.

Of these, Polymerase Chain Reactions (PCR) covered the maximum share in the global market in 2018. The easy availability and extensive use of this technology are responsible for this segment’s growth. Owing to the increasing number of genetic studies, the demand for genomics is expected to fuel in healthcare facilities & diagnostic centers, Contract Research Organization (CROs) and others.

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue.

Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

TOC followed by:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4 Market Trends
4.Key Insights
4.1GenomicsResearch Spending - For Key Countries, 2018
4.2RegulatoryScenario - For Key Countries
4.3Overview of Genomics Service Provider
4.4New Product Launch
4.5Start-upswith their Funding Overview
4.5Key Industry Developments - Mergers, Acquisitions and Partnerships
5.Global Genomics Market Analysis, Insights and Forecast, 2015-2026
5.1.Key Findings / Summary
5.2.Market Analysis, Insights and Forecast – By Type
5.2.1Product
5.2.1.1Instruments& Software
5.2.1.2Consumables
5.2.2Services

More Trending Topics from Future Business Insights:

Hemostatic Agents Market to reach US$ 5,441.5 Mn by 2025, at a CAGR of 6.4% | Exclusive Report by Fortune Business Insights

Global Commercial Seed Market to Value US$ 61.32 Bn by 2025, Increasing Subsidies Provided to Farmers will Boost Market, says Fortune Business Insights

Cardiovascular Stents Market to Exhibit 6.6% CAGR, Development of Bioresorbable Stents to Boost Market, Says Fortune Business Insights

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt. Ltd
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/genomics-market-size-to-be-worth-us-626146-mn-by-2026/88899084

Source: MarketersMedia

Release ID: 88899084

Other News

Harvey Weinstein wants to move trial out of NYC

Aug 21, 2019

NEW YORK — A lawyer for Harvey Weinstein has asked that the disgraced movie mogul's upcoming criminal trial be moved out of New York City, saying he can't get a fair trial. In a longshot motion filed with the state appellate court on Friday, attorney Arthur Aidala suggested the trial be moved to upstate Albany County or Suffolk County on Long Island. Aidala cited the intense media coverage and the circuslike atmosphere surrounding Weinstein's past court appearances in Manhattan. The 67-year-old Weinstein is charged with raping a woman in 2013 and performing a forcible sex act on a different woman...

Cowboys' Elliott won't face criminal charge in Vegas scuffle

Aug 21, 2019

LAS VEGAS — Dallas Cowboys star running back Ezekiel Elliott won't face criminal charges after scuffling with a music festival security guard in Las Vegas. Prosecutor Steve Wolfson said Tuesday the findings of a police investigation "lacked prosecutorial merit." The NFL said last month that Elliott didn't violate league personal conduct rules and wouldn't face suspension. Elliott was handcuffed but not arrested after police said he pushed a security guard to the ground at the event last May at Las Vegas Motor Speedway. Cellphone video obtained by celebrity website TMZ showed an event staffer stumbling over a parking barrier after...

Review: In 'Brittany Runs a Marathon,' a breakout for Bell

Aug 21, 2019

Getting in shape and putting your life together usually, at the movies, passes in a montage. But for many, the non-Rocky legions of us, such transformations require more than inspiring theme music and lifting weights in the snow. And for the Brittany (Jillian Bell) of "Brittany Runs a Marathon," that's especially true. Brittany is an aimless and broke 20-something in New York who's startled when her attempt to pry an Adderall prescription from a doctor (Patch Darragh) turns into a recommendation to improve her body mass index. He suggests she changes her hard-drinking lifestyle and lose about 50 pounds. After...

Calls for action from Twitter after Pogba gets racist abuse

Aug 21, 2019

LONDON — Manchester United defender Harry Maguire called on social media companies to require users to verify their identities after teammate Paul Pogba was targeted on Twitter with racial abuse. Racially offensive tweets about Pogba were posted after his penalty kick was saved in United's 1-1 draw at Wolverhampton Wanderers in the English Premier League on Monday. The 20-time English champions said they "encourage social media companies to take action in these cases" and Maguire offered a solution. "Every account that is opened should be verified by a passport/driving license. Stop these pathetic trolls making numerous accounts to abuse people,"...

Pell's appeal pitted word of former choirboy against priest

Aug 21, 2019

CANBERRA, Australia — Cardinal George Pell's appeal against his convictions for child molestation was largely a question of who the jury should have believed, his accuser or a senior priest whose church role was likened to Pell's bodyguard. Pell's accuser was a 13-year-old choirboy when he alleged that he was abused by then-Melbourne Archbishop Pell at the city's St. Patrick's Cathedral in December 1996 and February 1997. Monsignor Charles Portelli was a master of ceremonies at the 11 a.m. Sunday Masses where the choir sang. A chorister in the 1990s, David Dearing, told police that Portelli, Pell's right-hand man, was...

Enter Wicked dives into the Entertainment World seeking to report the hot topics going on with celebrities.

Contact us: sales@enterwicked.com